Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia
Restricted accessLetterFirst published online August, 2013
Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia
WeinerHL. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?Ann Neurol2009; 65: 239–248.
2.
OliverCStaceyCKRichardD. Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis. J Clin Immunol2011; DOI: 10.1007/s10875-011-9579-6.
3.
SigurdurYKMagnusBMalinH. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol2011; 29: 2897–2903.
4.
KoehlerNKRoebbertMDehghaniK. Up-regulation of platelet-derived growth factor by peripheral-blood leukocytes during experimental allergic encephalomyelitis. J Neurosci Res2008; 86: 392–402.
5.
PaniaguaRTOrrSHOPP. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest2006; 116: 2633–2642.
